[ET Net News Agency, 31 July 2019] CK Life Sciences Int'l., (Holdings) Inc. (00775)
said it recorded unaudited profit attributable to shareholders of HK171 million for the
six months ended 30 June 2019, similar to that of the corresponding period last year. The
earnings per share were HK1.78 cent. The board of directors has not declared any interim
dividend for the period.
The revenue was HK$2.6 billion, a year-on-year increase of 2.18%. (RC)